What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · Hannah Beier/Reuters. CNN — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 …
May 22, 2024 · A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four years. The medication shows significant cardiovascular benefits and appears to reduce the risk of …
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ …
Aug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
“Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or...
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy users keep weight off for 4 years, new analysis finds - NBC News
May 14, 2024 · Reuters. Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments...
FDA approves Wegovy, a new drug to fight obesity - CBS News
Jun 10, 2021 · The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.
Where Ozempic, Wegovy and New Weight Loss Drugs Came …
Aug 17, 2023 · Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it’s a Band-Aid, not a fix.
Wegovy's heart benefits due to more than weight loss, Novo says
PHILADELPHIA, Nov 11 (Reuters) - Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone,...
Weight-loss drug Wegovy cuts risk of stroke, heart attacks ... - NBC News
Aug 8, 2023 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the first to demonstrate...